(S)-2-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

(6-Bromo-4-chloropyridin-2-yl)methanol, 97%, 250mg

2-Amino-5-methyl-4-phenylthiophene-3-carboxylic acid methyl ester, 95.0%, 100mg

4-Bromoisoxazole, 95.0%, 10g

2,3-Bis(trifluoromethyl)pyrazine, 97.0%, 5g

1-Bromo-3-ethoxy-4-methoxybenzene, 95.0%, 250mg

2-(piperidin-1-ylmethyl)phenol, 95.0%, 250mg

2-(4-Methylbenzoyl)oxazole, 97.0%, 1g

2-(4-Hydroxyphenyl)-4-methyl-thiazole-5-carboxylic acid ethyl ester, 97.0%, 500g

methyl 2-(6-chloro-2-iminobenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 250mg

3-Chloroisoquinoline-5-carbonitrile, 98%, 1g

2-Chloro-4-iodo-6-(trifluoromethyl)pyridine, 97.0%, 50g

Plan stress-free PLPOLi 100x/0.80 IOS objective for iScope incident polarization, no cover glass correction. Working distance 2 mm